Drug Combo Slows Advanced Pancreatic Cancer - Mayo Clinic

582 views · Published 3 April 2012 · 1:49 · Indexed 10 November 2026

Channel: Mayo Clinic · 2012 · Science & Technology

Watch on YouTube

Lead researcher Mitesh Borad, M.D., of Mayo Clinic in Arizona, discusses results  of a multi-center Phase II clinical trial, which shows that patients receiving the combination of gemcitabine and TH-302 demonstrated a progression-free survival of 5.6 months compared to 3.6 months in those patients who received gemcitabine alone.

More from this channel

• 2:19 Nose Job for Snoring-Mayo Clinic

  Mayo Clinic

  3,709 views · 7 May 2008

• 1:54 Jazz Doctor-Mayo Clinic

  Mayo Clinic

  1,248 views · 7 May 2008

• 2:07 Healthy Heart Numbers - Mayo Clinic

  Mayo Clinic

  4,698 views · 12 May 2008

• 2:09 Managing Your Medications-Mayo Clinic

  Mayo Clinic

  1,209 views · 13 May 2008

• 1:54 Exercise Safety - Mayo Clinic

  Mayo Clinic

  1,507 views · 13 May 2008

• 2:16 Kids Eating Healthy-Mayo Clinic

  Mayo Clinic

  3,544 views · 23 May 2008

• 2:09 Sports Rehabilitation and Performance-Mayo Clinic

  Mayo Clinic

  4,222 views · 27 May 2008

• 2:17 Transplant Advances-Mayo Clinic

  Mayo Clinic

  860 views · 27 May 2008